GSK to buy HIV drugs from Bristol-Myers Squibb
December 18, 2015 at 02:15 AM EST
LONDON, Dec 18 (Reuters) - British pharmaceutical company GlaxoSmithKline said it would buy HIV drugs at different stages of development from U.S. rival Bristol-Myers Squibb in a deal which would boost its ViiV Healthcare unit.